Sarepta Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Sarepta Therapeutics, a leader in precision genetic medicine, announced participation in two upcoming virtual investor conferences. Management will speak at the Cowen 41st Annual Health Care Conference on Mar. 3, 2021, at 2:40 p.m. E.T., and at the Barclays Global Healthcare Conference on Mar. 10, 2021, at 2:25 p.m. E.T.. Both presentations will be available via live webcasts on Sarepta's website and archived for 90 days. The company focuses on genetic treatments for rare diseases, including Duchenne muscular dystrophy, with over 40 development programs.

CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:

• Cowen 41st Annual Health Care Conference on Wednesday, Mar. 3, 2021 at 2:40 p.m. E.T.
• Barclays Global Healthcare Conference on Wednesday, Mar. 10, 2021 at 2:25 p.m. E.T.

The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
At Sarepta, we are leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with rare disease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development. The Company’s programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the ‘For Investors’ section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.  

Source: Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.
Investors:
Ian Estepan, 617-274-4052, iestepan@sarepta.com

Media:
Tracy Sorrentino, 617-301-8566, tsorrentino@sarepta.com

FAQ

What events is Sarepta Therapeutics participating in March 2021?

Sarepta Therapeutics will participate in the Cowen 41st Annual Health Care Conference on March 3, 2021, at 2:40 p.m. E.T., and the Barclays Global Healthcare Conference on March 10, 2021, at 2:25 p.m. E.T.

Where can I watch the Sarepta Therapeutics presentations?

The presentations will be webcast live on Sarepta's website and archived for 90 days.

What is the primary focus of Sarepta Therapeutics?

Sarepta Therapeutics specializes in precision genetic medicine for rare diseases, particularly Duchenne muscular dystrophy and gene therapies for other conditions.

How many programs does Sarepta Therapeutics have in development?

Sarepta Therapeutics has more than 40 programs in various stages of development.

How can investors get updates about Sarepta Therapeutics?

Investors can visit Sarepta's investor relations section on their website for important updates and presentations.